The mixture was effective in all human cancer cells tested, such as M14 and HeLa (Figure 2A and C), in addition to both wild-type (Figure 2D) and p53−/−(Figure 2E) HCT116 cells, with 54%, 47%, 50%, and 58% inhibition at 24 h vs cells grown in culture medium alone, respectively. Here, TP53 is linked to cancer.